Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)

Historical Holders from Q1 2024 to Q3 2025

Symbol
TELO on Nasdaq
Type / Class
Equity / Common Stock, no par value
Shares outstanding
32,270,909
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,332,205
Holdings value
$3,240,559
% of all portfolios
0%
Number of holders
31
Number of buys
13
Number of sells
-30
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DEJORIA JOHN PAUL 5.5% $2,626,852 1,774,900 John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity 09 Sep 2025

Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2,332,205 $3,240,559 -$616,944 $1.39 31
2025 Q2 2,807,449 $3,509,640 -$1,509,843 $1.25 42
2025 Q1 3,692,775 $11,927,929 +$377,557 $3.23 42
2024 Q4 3,563,053 $14,680,234 +$6,102,927 $4.12 37
2024 Q3 2,045,931 $13,136,057 +$9,006,860 $6.42 33
2024 Q2 361,326 $1,737,881 +$1,328,649 $4.81 24
2024 Q1 79,917 $413,466 +$413,466 $5.15 7